1 / 20

Enzymes, Cardiac Markers, Hepatic Tests

Enzymes, Cardiac Markers, Hepatic Tests. clinically useful enzymes: tissue sources preanalytical variables affecting enzyme activities isoenzymes myocardial markers and diagnosis of myocardial injury hepatic function, choice of tests, interpretation of results. Clinically Useful Enzymes.

tehya
Télécharger la présentation

Enzymes, Cardiac Markers, Hepatic Tests

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Enzymes, Cardiac Markers, Hepatic Tests • clinically useful enzymes: tissue sources • preanalytical variables affecting enzyme activities • isoenzymes • myocardial markers and diagnosis of myocardial injury • hepatic function, choice of tests, interpretation of results

  2. Clinically Useful Enzymes • LDH: heart, liver, muscle, RBC, neural tissue, leukocytes, tumor cells • AST: liver, heart, muscle • ALT: liver • CK: muscle, heart, neural tissue • ALP: liver, bone, intestine, placenta • GGT: liver, pancreas, kidney

  3. Preanalytical Variables • IN THE PATIENT - age, sex, food, exercise, trauma • IN THE SAMPLE • Hemolysis -inc in Total LDH & LDH 1/II • EDTA: inhibition of ALP

  4. CK Isoenzymes • Dimer: M & B monomers • CK- 1: BB; neural & mesenchymal tissue • CK- 2: MB; muscle (<1%); heart (<40%) • CK- 3: MM; heart (60 - 80%) muscle (>99%)

  5. CK Isoforms • CKMM-3 & CKMB-2 (tissue isoforms of CK) after tissue release are converted by carboxypeptidases in blood to:- CKMM-2 & CKMM-1, and- CKMB-1

  6. Detection of Myocardial Injury Major Issues • THE Acute Coronary Syndrome - stable angina - unstable angina - acute myocardial infarction • Choice of biochemical cardiac marker

  7. Acute Coronary Syndrome: Risk Stratification • Chest pain • ECG – ST segment changes • Troponins • Other risk factors: CRP, fibrinogen, BNP

  8. Myocardial Markers • Troponin-I or T • Myoglobin • CK- MB • CK- MB Relative Index • CK Isoforms

  9. Myocardial Markers

  10. Myocardial Markers:References • Donnelly, R, Millar-Craig, MW: Cardiac troponins: IT upgrade for the heart. Lancet 1998;351:537-9 • Apple,FS & Wu,A: Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001; 47:377-8 • Sabatine, MS et al: Multimarker approach to risk stratification in non-ST elevation ACS. Circulation 2002; 105:1760-3

More Related